Section for Pharmaceuticals
The pharmaceuticals unit is responsible for regulating products and the market for medicinal products and medical devices. This involves rules for placing and keeping those products on the market, HTA and reimbursement, and the rules governing manufacturers, wholesalers and pharmacies – from clinical trials to the products reach the end users.
The section is responsible for both economic and legal instruments, including reimbursement under the Blue Prescription Regulations. The section also has formal management responsibility for the Norwegian Medical Products Agency. The director of the section is Jan Berg.